Cwm LLC Sells 2,164 Shares of Nu Skin Enterprises, Inc. $NUS

Cwm LLC reduced its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 9.7% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,193 shares of the company’s stock after selling 2,164 shares during the quarter. Cwm LLC’s holdings in Nu Skin Enterprises were worth $161,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC grew its stake in shares of Nu Skin Enterprises by 102.0% in the first quarter. GAMMA Investing LLC now owns 3,498 shares of the company’s stock worth $25,000 after acquiring an additional 1,766 shares during the period. PAX Financial Group LLC grew its stake in shares of Nu Skin Enterprises by 5.0% in the first quarter. PAX Financial Group LLC now owns 38,473 shares of the company’s stock worth $279,000 after acquiring an additional 1,840 shares during the period. Inspire Investing LLC grew its stake in shares of Nu Skin Enterprises by 4.8% in the second quarter. Inspire Investing LLC now owns 48,794 shares of the company’s stock worth $390,000 after acquiring an additional 2,250 shares during the period. SummerHaven Investment Management LLC grew its position in Nu Skin Enterprises by 3.1% in the 2nd quarter. SummerHaven Investment Management LLC now owns 82,344 shares of the company’s stock worth $658,000 after purchasing an additional 2,484 shares during the period. Finally, Amundi grew its position in Nu Skin Enterprises by 18.8% in the 1st quarter. Amundi now owns 18,564 shares of the company’s stock worth $127,000 after purchasing an additional 2,941 shares during the period. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Trading Down 0.1%

Shares of Nu Skin Enterprises stock opened at $10.64 on Friday. The company has a market capitalization of $526.53 million, a P/E ratio of 5.29 and a beta of 0.97. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.38 and a current ratio of 2.01. The company has a fifty day moving average of $11.55 and a 200 day moving average of $9.25. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $14.62.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.18. The company had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 2.3%. The ex-dividend date was Friday, August 29th. Nu Skin Enterprises’s dividend payout ratio is presently 11.94%.

Analysts Set New Price Targets

NUS has been the subject of several research analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Wednesday, October 8th. Wall Street Zen upgraded Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 12th. Finally, Zacks Research upgraded Nu Skin Enterprises to a “hold” rating in a research note on Tuesday, August 12th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $7.00.

Insiders Place Their Bets

In related news, EVP Chayce David Clark sold 20,000 shares of the company’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total transaction of $239,400.00. Following the completion of the transaction, the executive vice president owned 233,140 shares in the company, valued at approximately $2,790,685.80. This represents a 7.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel W. Campbell sold 23,391 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the transaction, the director owned 53,375 shares of the company’s stock, valued at approximately $645,837.50. This represents a 30.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 58,926 shares of company stock worth $711,364 in the last three months. 2.00% of the stock is owned by company insiders.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.